Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial. (nature.com)

Authors: Sullivan RJ … Gulley JL Journal: Nature Medicine Published: 2026-10-23 DOI: https://doi.org/10.1038/s41591-026-04711-0